Money flows to medtech deals and financings
Medtech Trends to Watch 2025
The stage is set for a significantly more active year of M&A in Medtech. Financings, too, have ticked up and we expect the trend to continue, despite uncertainty roiling the broader market. This year has shown trends toward both a desire to increase focus on profitable core business and to build out portfolios in growing markets.
Even Medtronic plc which has been quiet on the deal-making front recently is “on the hunt for tuck-in M&A that leverages our existing businesses and that will also enhance our growth and our margin profile,” according to CEO Geoff Martha.
Download our new snapshot to read more and see data on the current M&A and financing trends.
Request more information
Actionable intelligence on advances in medical devices and technology
With writers and editors stationed around the globe, BioWorld MedTech, published by Clarivate, reports the breaking news and provides key perspectives on thousands of innovative medical technologies and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes.
Receive daily news about emerging medical technologies with the context and insights needed to inform your decisions with a subscription to BioWorld MedTech.
Stay ahead of future regulatory, political and even environmental trends
Medtech 360
Understand the current and future potential of your specific markets and gain a comprehensive view of the medtech competitive landscape.
- 80+ device markets, 50+ countries, 13 therapeutic areas 250+ medtech companies including 18 of the top 20 rely on Medtech 360 for market data and insights
- Diverse coverage of medtech markets across therapy/specialty areas: aesthetics, cardiovascular, dental, diagnostics, endoscopy & open surgery, gynecology, healthcare IT, orthopedics, reprocessing & sterilization, urology, wound care, other medical technology.
DRG Medtech Competitive Intelligence
Gain a better understanding of who your competitors are, what they offer, when they will launch, and how you can win, curated and enhanced by Clarivate’s medtech subject-matter experts.
One platform for all medtech competitive intelligence needs. Built for medtech, by medtech.
Commercial Targeting
Navigate the complex U.S. healthcare market and pinpoint diagnosis and procedure hotspots in Europe.
DRG Commercial Analytics 360
- A real-world data driven analytics solution to navigate the complex U.S. healthcare provider landscape and increase commercial effectiveness
- Capturing data from over 200 million annual patients and a repository covering over 3 million unique providers.
EU Procedure Finder
- Strategic medtech commercial targeting for European markets
- A comprehensive hospital directory covering 25 countries in Europe, listing details of each
hospital - 120+ attributes can also be populated for each hospital, including departments, psychiatry services, laboratories, diagnostic services, imaging & equipment, and more.
Market Tracking
Elevate your brand strategy to new heights with precision market tracking, built for medtech products and markets.
PriceTrack
- Real-time data solution that provides detailed, SKU-level hospital purchase order data to help our clients understand the share, price and market trends necessary to market their
brands effectively. - 1900 US Hospitals, 2.2 M Unique SKUs, >3K manufacturers.
U.S. Medical Supply Distribution
- Leveraging SKU-level distributor sales data, Clarivate provides a singular, comprehensive view of medical equipment and supply data in the distribution sales channel.
Global Market Tracking
- Examine market size, share and trends in LATAM, North America, Europe, Eastern Europe, Middle East and Asia- Pacific.
- Compare manufacturer portfolios, revenue and prices.
- Track regional and country-specific trends revenue, prices and trends.
- Broad coverage of global market and segments.
AMR Diagnostic Imaging
- AMR provides a granular view on procedures, products, manufacturers, reasons for procedure, and referring physician for six imaging modalities.
- 140+ Unique procedures, 100+ Unique products, 50+ manufacturers, 250+ reasons and physicians.
Key questions answered
Market Insights
- What is the market size and opportunity? Where is the market growing the most?
- Who are the market share leader(s)? Who is gaining/losing share? Are there new entrants to be concerned about?
- What trends are driving the market segments we operate in or are entering/exiting?
- What is the trajectory for a market segment under consideration for investment/divestment?
Market Tracking
- What product segments are growing / declining?
- What is the product mix within my competitor’s portfolio?
- What is the real-time market pricing for different products?
- How are brand shares changing over time and how much is pricing strategy contributing to these changes?
- What are the competing treatments for the same patient population?
Commercial Targeting
- What is the patient population for a specific therapy / procedure?
- Who is diagnosing and treating these patients and where? What are the referral patterns?
- What is the payer mix and how do payments differ by provider type?
- What regions / accounts are we prioritizing? Are there IDNs/ systems that require an enterprise sales approach?
- What accounts am I underpenetrated today and how do I expand share?